Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges
MAY 19, 2016
Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The specific violations of HIPAA have not been made public, but an Aegerion spokesperson stated that it “does not relate to a breach of our privacy or security with respect to patient health information.”. Enforcement Health Privacy U.S.